참고문헌 (103)

1. Alcayaga-Miranda F. Cuenca J. Khoury M. ( 2017 ). Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies. Front. Immunol. 8 : 339 . 10.3389/fimmu.2017.00339 28424688 

   상세보기

2. Allegra A. Di Gioacchino M. Tonacci A. Musolino C. Gangemi S. ( 2020 ). Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications. Int. J. Mol. Sci. 21 : 4782 . 10.3390/ijms21134782 32640747 

   상세보기

3. Arabi Y. M. Mandourah Y. Al-Hameed F. Sindi A. A. Almekhlafi G. A. Hussein M. A. ( 2018 ). Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome. Am. J. Respir. Crit. Care Med. 197 757 ？ 767 . 29161116 

   상세보기

4. Armitage J. Tan D. B. A. Troedson R. Young P. Lam K.-V. Shaw K. ( 2018 ). Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study. Eur. Respir. J. 51 : 1702369 . 10.1183/13993003.02369-2017 29348155 

   상세보기

5. Atluri S. Manchikanti L. Hirsch J. A. ( 2020 ). Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ILL COVID-19 patients: the case for compassionate use. Pain Physician 23 E71 ？ E84 . 32214286 

   상세보기

6. Bari E. Ferrarotti I. Torre M. L. Corsico A. G. Perteghella S. ( 2019 ). Mesenchymal stem/stromal cell secretome for lung regeneration: the long way through “pharmaceuticalization” for the best formulation. J. Control. Release 309 11 ？ 24 . 10.1016/j.jconrel.2019.07.022 31326462 

   상세보기

7. Barrett A. N. Fong C.-Y. Subramanian A. Liu W. Feng Y. Choolani M. ( 2018 ). Human Wharton’s jelly mesenchymal stem cells show unique gene expression compared with bone marrow mesenchymal stem cells using single-cell RNA-sequencing. Stem Cells Dev. 28 196 ？ 211 . 10.1089/scd.2018.0132 30484393 

   상세보기

8. Baruah V. Bose S. ( 2020 ). Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J. Med. Virol. 92 495 ？ 500 . 10.1002/jmv.25698 32022276 

   상세보기

9. Basalova N. Sagaradze G. Arbatskiy M. Evtushenko E. Kulebyakin K. Grigorieva O. ( 2020 ). Secretome of mesenchymal stromal cells prevents myofibroblasts differentiation by transferring fibrosis-associated microRNAs within extracellular vesicles. Cells 9 : 1272 . 10.3390/cells9051272 32443855 

   상세보기

10. Beigel J. H. Tomashek K. M. Dodd L. E. Mehta A. K. Zingman B. S. Kalil A. C. ( 2020 ). Remdesivir for the treatment of covid-19 ― preliminary report. N. Engl. J. Med. 10.1056/NEJMoa2007764 [Epub ahead of print] . 32445440 

    상세보기

11. Bjorge I. M. Kim S. Y. Mano J. F. Kalionis B. Chrzanowski W. ( 2018 ). Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair. Biomater. Sci. 6 60 ？ 78 . 10.1039/c7bm00479f 29184934 

    상세보기

12. Borger V. Weiss D. J. Anderson J. D. Borras F. E. Bussolati B. Carter D. R. F. ( 2020 ). International society for extracellular vesicles and international society for cell and gene therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy 22 482 ？ 485 . 10.1016/j.jcyt.2020.05.002 32425691 

    상세보기

13. Chen G. Chen D. Z. Li J. Czura C. J. Tracey K. J. Sama A. E. ( 2004 ). Pathogenic role of HMGB1 in SARS? Med. Hypotheses 63 691 ？ 695 . 10.1016/j.mehy.2004.01.037 15325019 

    상세보기

14. Chen G. Wu D. Guo W. Cao Y. Huang D. Wang H. ( 2020 ). Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130 2620 ？ 2629 . 10.1172/jci137244 32217835 

    상세보기

15. Chen L. Liu H. G. Liu W. Liu J. Liu K. Shang J. ( 2020 ). [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 43 : E005 . 

16. Chinese Clinical Trial Registry ( 2020 ). Available online at: http://www.chictr.org.cn (accessed June 26, 2020) . 

17. ClinicalTrials.gov ( 2020 ). Available online at: https://clinicaltrials.gov/ (accessed September 6, 2020) . 

18. Cruz F. F. Rocco P. R. M. ( 2020 ). The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev. Respir. Med. 14 31 ？ 39 . 10.1080/17476348.2020.1679628 31608724 

    상세보기

19. Derkus B. Emregul K. C. Emregul E. ( 2017 ). A new approach in stem cell research-exosomes: their mechanism of action via cellular pathways. Cell Biol. Int. 41 466 ？ 475 . 10.1002/cbin.10742 28191696 

    상세보기

20. Deshmukh V. Tripathi S. C. Pandey A. Deshmukh V. Vykoukal J. Patil A. ( 2020 ). CoviD-19: a conundrum to decipher. Eur. Rev. Med. Pharmacol. Sci. 24 5830 ？ 5841 . 32495923 

21. Deshpande C. ( 2020 ). Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism? Ann. Int. Med. 10.7326/M20-3255 [Epub ahead of print] . 32422061 

    상세보기

22. Devaney J. Horie S. Masterson C. Elliman S. Barry F. O’Brien T. ( 2015 ). Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 70 625 ？ 635 . 10.1136/thoraxjnl-2015-206813 25986435 

    상세보기

23. El Andaloussi S. Mager I. Breakefield X. O. Wood M. J. ( 2013 ). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 347 ？ 357 . 10.1038/nrd3978 23584393 

    상세보기

24. El Omar R. Beroud J. Stoltz J. Menu P. Velot E. Decot V. ( 2014 ). Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell based therapies? Tissue Eng. Part B Rev. 20 523 ？ 544 . 10.1089/ten.teb.2013.0664 24552279 

    상세보기

25. Fong C. Chak L. Biswas A. Tan J. Gauthaman K. Chan W. ( 2011 ). Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. Rep. 7 1 ？ 16 . 10.1007/s12015-010-9166-x 20602182 

    상세보기

26. Gao F. Chiu S. M. Motan D. A. L. Zhang Z. Chen L. Ji H. L. ( 2016 ). Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 7 : e2062 . 10.1038/cddis.2015.327 26794657 

    상세보기

27. Gao J. Tian Z. Yang X. ( 2020 ). Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends 14 72 ？ 73 . 10.5582/bst.2020.01047 32074550 

    상세보기

28. Gao Y. Li T. Han M. Li X. Wu D. Xu Y. ( 2020 ). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 92 791 ？ 796 . 10.1002/jmv.25770 32181911 

    상세보기

29. Giri J. Galipeau J. ( 2020 ). Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv. 4 1987 ？ 1997 . 10.1182/bloodadvances.2020001711 32384543 

    상세보기

30. Golchin A. Seyedjafari E. Ardeshirylajimi A. ( 2020 ). Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev. Rep. 16 427 ？ 433 . 10.1007/s12015-020-09973-w 32281052 

    상세보기

31. Gorbalenya A. E. Baker S. C. Baric R. S. de Groot R. J. Drosten C. Gulyaeva A. A. ( 2020 ). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5 536 ？ 544 . 10.1038/s41564-020-0695-z 32123347 

    상세보기

32. Group T. R. C. ( 2020 ). Dexamethasone in hospitalized patients with Covid-19 ― preliminary report. N. Engl. J. Med. 10.1056/NEJMoa2021436 [Epub ahead of print] . 32678530 

    상세보기

33. Han P. L. Pang T. Diao K. Y. Yang Z. G. ( 2020 ). Corona virus disease 2019 (COVID-19): the image tells the truth. Infection 10.1007/s15010-020-01431-6 [Epub ahead of print] . 32385842 

    상세보기

34. Harrell C. R. Sadikot R. Pascual J. Fellabaum C. Jankovic M. G. Jovicic N. ( 2019 ). Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives. Stem Cells Int. 2019 : 4236973 . 

35. Henderson L. A. Canna S. W. Schulert G. S. Volpi S. Lee P. Y. Kernan K. F. ( 2020 ). On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 72 1059 ？ 1063 . 32293098 

36. Hoffmann M. Kleine-Weber H. Pohlmann S. ( 2020 ). A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78 779 ？ 784.e5 . 32362314 

37. Hu S. Park J. Liu A. Lee J. Zhang X. Hao Q. ( 2018 ). Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells. Stem Cells Transl. Med. 7 615 ？ 624 . 10.1002/sctm.17-0278 29737632 

    상세보기

38. Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. ( 2020 ). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 497 ？ 506 . 31986264 

39. Johnson R. M. Vinetz J. M. ( 2020 ). Dexamethasone in the management of covid -19. BMJ 370 : m2648 . 10.1136/bmj.m2648 32620554 

    상세보기

40. Kamal M. M. Kassem D. H. ( 2020 ). Therapeutic potential of Wharton’s jelly mesenchymal stem cells for diabetes: achievements and challenges. Front. Cell Dev. Biol. 8 : 16 . 10.3389/fcell.2020.00016 32064260 

    상세보기

41. Khoury M. Cuenca J. Cruz F. F. Figueroa F. E. Rocco P. R. M. Weiss D. J. ( 2020 ). Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur. Respir. J. 55 : 2000858 . 10.1183/13993003.00858-2020 32265310 

    상세보기

42. Kindler E. Thiel V. ( 2016 ). SARS-CoV and IFN: too little, too late. Cell Host Microbe 19 139 ？ 141 . 10.1016/j.chom.2016.01.012 26867172 

    상세보기

43. Land W. G. ( 2020 ). Use of DAMPs and SAMPs as therapeutic targets or therapeutics: a note of caution. Mol. Diagn. Ther. 24 251 ？ 262 . 10.1007/s40291-020-00460-z 32248387 

    상세보기

44. Lee J. W. Krasnodembskaya A. McKenna D. H. Song Y. Abbott J. Matthay M. A. ( 2013 ). Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am. J. Respir. Crit. Care Med. 187 751 ？ 760 . 10.1164/rccm.201206-0990oc 23292883 

    상세보기

45. Leiva-Juarez M. M. Kolls J. K. Evans S. E. ( 2018 ). Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol. 11 21 ？ 34 . 10.1038/mi.2017.71 28812547 

    상세보기

46. Leng Z. Zhu R. Hou W. Feng Y. Yang Y. Han Q. ( 2020 ). Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia. Aging Dis. 11 216 ？ 228 . 10.14336/ad.2020.0228 32257537 

    상세보기

47. Li H. Liu S. M. Yu X. H. Tang S. L. Tang C. K. ( 2020 ). Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents 55 : 105951 . 

48. Liu X. Feng T. Gong T. Shen C. Zhu T. Wu Q. ( 2015 ). Human umbilical cord mesenchymal stem cells inhibit the function of allogeneic activated Vγ9Vδ2 T lymphocytes in vitro. Biomed Res. Int. 2015 : 317801 . 

49. Liu Z. Long W. Tu M. Chen S. Huang Y. Wang S. ( 2020 ). Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J. Infect. 81 318 ？ 356 . 10.1016/j.jinf.2020.03.054 32283159 

    상세보기

50. Ma S. Xie N. Li W. Yuan B. Shi Y. Wang Y. ( 2014 ). Immunobiology of mesenchymal stem cells. Cell Death Differ. 21 216 ？ 225 . 24185619 

    상세보기

51. Mahase E. ( 2020 ). Covid-19: demand for dexamethasone surges as RECOVERY trial publishes preprint. BMJ 369 : m2512 . 10.1136/bmj.m2512 32576548 

    상세보기

52. Malcherek G. Jin N. Huckelhoven A. G. Mani J. Wang L. Gern U. ( 2014 ). Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells. Leukemia 28 2388 ？ 2394 . 10.1038/leu.2014.273 25227910 

    상세보기

53. Matthay M. A. ( 2015 ). Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Ann. Am. Thorac. Soc. 12 ( Suppl. 1 ), S54 ？ S57 . 25830837 

54. Mehta P. McAuley D. F. Brown M. Sanchez E. Tattersall R. S. Manson J. J. ( 2020 ). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395 1033 ？ 1034 . 10.1016/s0140-6736(20)30628-0 32192578 

    상세보기

55. Meng F. Xu R. Wang S. Xu Z. Zhang C. Li Y. ( 2020 ). Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct. Target. Ther. 5 : 172 . 

56. Meselson M. ( 2020 ). Droplets and aerosols in the transmission of SARS-CoV-2. N. Engl. J. Med. 382 : 2063 . 10.1056/nejmc2009324 32294374 

    상세보기

57. Moll G. Ankrum J. A. Kamhieh-Milz J. Bieback K. Ringden O. Volk H.-D. ( 2019 ). Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol. Med. 25 149 ？ 163 . 10.1016/j.molmed.2018.12.006 30711482 

    상세보기

58. Moll G. Drzeniek N. Kamhieh-Milz J. Geissler S. Volk H. D. Reinke P. ( 2020 ). MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy. Front. Immunol. 11 : 1091 . 10.3389/fimmu.2020.01091 32574263 

    상세보기

59. Nelemans T. Kikkert M. ( 2019 ). Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses 11 : 961 . 10.3390/v11100961 31635238 

    상세보기

60. Newton W. C. Kim J. W. Luo J. Z. Q. Luo L. ( 2017 ). Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy. J. Mol. Endocrinol. 59 R155 ？ R165 . 28835418 

    상세보기

61. Okabayashi T. Kariwa H. Yokota S. Iki S. Indoh T. Yokosawa N. ( 2006 ). Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J. Med. Virol. 78 417 ？ 424 . 10.1002/jmv.20556 16482545 

    상세보기

62. Ortiz L. A. Gambelli F. McBride C. Gaupp D. Baddoo M. Kaminski N. ( 2003 ). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U.S.A. 100 8407 ？ 8411 . 10.1073/pnas.1432929100 12815096 

    상세보기

63. Perrotta F. Matera M. G. Cazzola M. Bianco A. ( 2020 ). Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter? Respir. Med. 168 : 105996 . 10.1016/j.rmed.2020.105996 32364961 

    상세보기

64. Pittenger M. F. Discher D. E. Peault B. M. Phinney D. G. Hare J. M. Caplan A. I. ( 2019 ). Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 4 : 22 . 

65. Qin C. Zhou L. Hu Z. Zhang S. Yang S. Tao Y. ( 2020 ). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71 762 ？ 768 . 10.1093/cid/ciaa248 32161940 

    상세보기

66. Rajarshi K. Chatterjee A. Ray S. ( 2020 ). Combating COVID-19 with mesenchymal stem cell therapy. Biotechnol. Rep. 26 : e00467 . 10.1016/j.btre.2020.e00467 32420049 

    상세보기

67. Rolandsson Enes S. Weiss D. J. ( 2020 ). Cell therapy for lung disease: current status and future prospects. Curr. Stem Cell Rep. 6 30 ？ 39 . 10.1007/s40778-020-00171-5 

    상세보기

68. Ruan Q. Yang K. Wang W. Jiang L. Song J. ( 2020 ). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46 846 ？ 848 . 10.1007/s00134-020-05991-x 32125452 

    상세보기

69. Russell B. Moss C. George G. Santaolalla A. Cope A. Papa S. ( 2020 ). Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 14 : 1022 . 

70. Savukinas U. B. Enes S. R. Sjoland A. A. Westergren-Thorsson G. ( 2016 ). Concise review: the bystander effect: mesenchymal stem cell-mediated lung repair. Stem Cells 34 1437 ？ 1444 . 10.1002/stem.2357 26991735 

    상세보기

71. Shang J. Wan Y. Luo C. Ye G. Geng Q. Auerbach A. ( 2020a ). Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 117 11727 ？ 11734 . 32376634 

    상세보기

72. Shang J. Ye G. Shi K. Wan Y. Luo C. Aihara H. ( 2020b ). Structural basis of receptor recognition by SARS-CoV-2. Nature 581 221 ？ 224 . 10.1038/s41586-020-2179-y 32225175 

    상세보기

73. Shetty P. Cooper K. Viswanathan C. ( 2010 ). Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J. Transfus. Sci. 4 14 ？ 24 . 10.4103/0973-6247.59386 20376261 

    상세보기

74. Shi Y. Wang Y. Shao C. Huang J. Gan J. Huang X. ( 2020 ). COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 27 1451 ？ 1454 . 10.1038/s41418-020-0530-3 32205856 

    상세보기

75. Shin D. Mukherjee R. Grewe D. Bojkova D. Baek K. Bhattacharya A. ( 2020 ). Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 10.1038/s41586-020-2601-5 [Epub ahead of print] . 32726803 

    상세보기

76. Silachev D. N. Goryunov K. V. Shpilyuk M. A. Beznoschenko O. S. Morozova N. Y. Kraevaya E. E. ( 2019 ). Effect of MSCs and MSC-derived extracellular vesicles on human blood coagulation. Cells 8 : 258 . 10.3390/cells8030258 30893822 

    상세보기

77. Silva J. D. de Castro L. L. Braga C. L. Oliveira G. P. Trivelin S. A. Barbosa-Junior C. M. ( 2019 ). Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology. Stem Cells Int. 2019 : 8262849 . 

78. Taghavi-Farahabadi M. Mahmoudi M. Soudi S. Hashemi S. M. ( 2020 ). Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Med. Hypotheses 144 : 109865 . 10.1016/j.mehy.2020.109865 32562911 

    상세보기

79. Taghdiri N. V. Soura M. Aliakbar Y. A. Amir A. Mehrnaz I. Fatemeh D. ( 2018 ). The extracellular vesicles-derived from mesenchymal stromal cells: a new therapeutic option in regenerative medicine. J. Cell. Biochem. 119 8048 ？ 8073 . 10.1002/jcb.26726 29377241 

    상세보기

80. Tang D. Comish P. Kang R. ( 2020 ). The hallmarks of COVID-19 disease. PLoS Pathog. 16 : e1008536 . 10.1371/journal.ppat.1008536 32442210 

    상세보기

81. Tang D. Kang R. Coyne C. B. Zeh H. J. Lotze M. T. ( 2012 ). PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 249 158 ？ 175 . 10.1111/j.1600-065x.2012.01146.x 22889221 

    상세보기

82. Tay M. Z. Poh C. M. Renia L. MacAry P. A. Ng L. F. P. ( 2020 ). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20 363 ？ 374 . 10.1038/s41577-020-0311-8 32346093 

    상세보기

83. Teijaro J. R. Walsh K. B. Rice S. Rosen H. Oldstone M. B. ( 2014 ). Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 111 3799 ？ 3804 . 10.1073/pnas.1400593111 24572573 

    상세보기

84. van Doremalen N. Bushmaker T. Morris D. H. Holbrook M. G. Gamble A. Williamson B. N. ( 2020 ). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382 1564 ？ 1567 . 32182409 

    상세보기

85. Velazquez-Salinas L. Verdugo-Rodriguez A. Rodriguez L. L. Borca M. V. ( 2019 ). The role of interleukin 6 during viral infections. Front. Microbiol. 10 : 1057 . 10.3389/fmicb.2019.01057 31134045 

    상세보기

86. Wang J. Jiang M. Chen X. Montaner L. J. ( 2020 ). Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 108 17 ？ 41 . 10.1002/jlb.3covr0520-272r 32534467 

    상세보기

87. Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. ( 2020 ). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30 269 ？ 271 . 10.1038/s41422-020-0282-0 32020029 

    상세보기

88. Waterman R. S. Tomchuck S. L. Henkle S. L. Betancourt A. M. ( 2010 ). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 5 : e10088 . 10.1371/journal.pone.0010088 20436665 

    상세보기

89. Weiss A. R. R. Dahlke M. H. ( 2019 ). Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front. Immunol. 10 : 1191 . 10.3389/fimmu.2019.01191 31214172 

    상세보기

90. Weiss M. L. Anderson C. Medicetty S. Seshareddy K. B. Weiss R. J. VanderWerff I. ( 2008 ). Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells 26 2865 ？ 2874 . 10.1634/stemcells.2007-1028 18703664 

    상세보기

91. Witkowski M. Landmesser U. Rauch U. ( 2016 ). Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc. Med. 26 297 ？ 303 . 10.1016/j.tcm.2015.12.001 26877187 

    상세보기

92. World Health Organization [WHO] ( 2020a ). World Health Organization Media Center. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed September 10, 2020) . 

93. World Health Organization [WHO] ( 2020b ). World Health Organization Media Center. Available at: https://www.who.int/westernpacific/emergencies/covid-19/information/high-risk-groups (accessed September 6, 2020) . 

94. Xu H. Zhong L. Deng J. Peng J. Dan H. Zeng X. ( 2020 ). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12 : 8 . 

95. Yang M. Cao L. Xie M. Yu Y. Kang R. Yang L. ( 2013 ). Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem. Pharmacol. 86 410 ？ 418 . 10.1016/j.bcp.2013.05.013 23707973 

    상세보기

96. Yen B. L. Yen M. L. Wang L. T. Liu K. J. Sytwu H. K. ( 2020 ). Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: gleaning insights for possible use in COVID-19. Stem Cells Transl. Med. 10.1002/sctm.20-0186 [Epub ahead of print] . 32526079 

    상세보기

97. Zaim S. Chong J. H. Sankaranarayanan V. Harky A. ( 2020 ). COVID-19 and multiorgan response. Curr. Probl. Cardiol. 45 : 100618 . 10.1016/j.cpcardiol.2020.100618 32439197 

    상세보기

98. Zenewicz L. A. ( 2018 ). IL-22: there is a gap in our knowledge. Immunohorizons 2 198 ？ 207 . 10.4049/immunohorizons.1800006 31022687 

    상세보기

99. Zhang J. Guan J. Niu X. Hu G. Guo S. Li Q. ( 2015 ). Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J. Transl. Med. 13 : 49 . 

100. Zhang W. Li L. Liu J. Chen L. Zhou F. Jin T. ( 2020 ). The characteristics and predictive role of lymphocyte subsets in COVID-19 patients. Int. J. Infect. Dis. 99 92 ？ 99 . 10.1016/j.ijid.2020.06.079 32758688 

     상세보기

101. Zhang Y. Ding J. Ren S. Wang W. Yang Y. Li S. ( 2020 ). Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res. Ther. 11 : 207 . 

102. Zhao L. Chen S. Yang P. Cao H. Li L. ( 2019 ). The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res. Ther. 10 : 182 . 

103. Zou X. Chen K. Zou J. Han P. Hao J. Han Z. ( 2020 ). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14 185 ？ 192 . 10.1007/s11684-020-0754-0 32170560 

     상세보기